Influence of patient co-payments on atypical antipsychotic choice in Poland
Market forces appear to drive down the prices of generics and originators as more atypical formulations are launched. However, alternative approaches may be needed if significant co-payment differences compromise individualized care. </AbstractSection> Copyright Adis Data Information BV 2011
Year of publication: |
2011
|
---|---|
Authors: | Wladysiuk, Magda ; Araszkiewicz, Aleksander ; Godman, Brian ; Szabert, Katarzyna ; Barbui, Corrado ; Haycox, Alan |
Published in: |
Applied Health Economics and Health Policy. - Springer, ISSN 1175-5652. - Vol. 9.2011, 2, p. 101-110
|
Publisher: |
Springer |
Saved in:
Online Resource
Saved in favorites
Similar items by person
-
Wladysiuk, Magda, (2011)
-
Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden
Godman, Brian, (2013)
-
Wettermark, Bjorn, (2008)
- More ...